ITGA4 and neoplasm: The delineation of ITGA4 as a poor prognostic factor was not surprising since increased expression of integrin α4β1 is associated with tumor progression and ECM components secreted by CAFs bind integrins to activate pro-tumorigenic pathways [41, 79, 80].